JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

JNJ

234.31

+0.56%↑

UNH

275.55

-2.98%↓

TMO

563.68

-0.84%↓

ABT

108.15

-0.74%↓

ISRG

478.08

-0.13%↓

Search

Pluristem Therapeutics Inc

Geschlossen

3.04 -10.32

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

2.93

Max

3.32

Dividenden

By Dow Jones

Nächstes Ergebnis

9. Feb. 2026

Pluristem Therapeutics Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

4. Feb. 2026, 22:55 UTC

Ergebnisse

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook -- Update

4. Feb. 2026, 21:44 UTC

Ergebnisse

Arm Holdings 3Q Profit Falls Despite Revenue Growth

4. Feb. 2026, 21:39 UTC

Ergebnisse

Qualcomm 1Q Sales Rise, But Memory Shortage Dents Outlook

4. Feb. 2026, 23:46 UTC

Ergebnisse

Arm Holdings Expects Slower Revenue Growth in 4Q -- Update

4. Feb. 2026, 23:46 UTC

Market Talk

Nikkei May Rise as Weaker Yen Supports Earnings Hopes -- Market Talk

4. Feb. 2026, 23:45 UTC

Heiße Aktien

Stocks to Watch: Crown Castle, Qualcomm, Arm, U-Haul

4. Feb. 2026, 23:45 UTC

Ergebnisse

Google to Double Spending as Earnings Beat Wall Street Expectations -- 4th Update

4. Feb. 2026, 23:32 UTC

Market Talk

Gold Rises on Possible Dip-Buying Amid Lingering U.S.-Iran Tensions -- Market Talk

4. Feb. 2026, 22:59 UTC

Akquisitionen, Fusionen, Übernahmen

SiTime to Buy Timing Business From Renesas Electronics For $1.5B

4. Feb. 2026, 22:30 UTC

Ergebnisse

Salesforce Stock Is Battered, and Super Cheap. Hang Tight. -- Barrons.com

4. Feb. 2026, 22:30 UTC

Ergebnisse

Alphabet's Cloud Is Shining as CapEx Heads Even Higher -- Barrons.com

4. Feb. 2026, 22:21 UTC

Ergebnisse

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4. Feb. 2026, 22:17 UTC

Market Talk

WiseTech Faces Risks in Both Directions From DSV's Progress -- Market Talk

4. Feb. 2026, 22:15 UTC

Market Talk

Santos Should Lay Out Strategic Plans at Annual Result -- Market Talk

4. Feb. 2026, 22:00 UTC

Market Talk

ESG Roundup: Market Talk

4. Feb. 2026, 21:53 UTC

Ergebnisse

Google to Double Spending as Earnings Beat Wall Street Expectations -- 3rd Update

4. Feb. 2026, 21:51 UTC

Ergebnisse

Snap Stock Pops After Surprise Earnings Beat -- Barrons.com

4. Feb. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4. Feb. 2026, 21:50 UTC

Market Talk
Akquisitionen, Fusionen, Übernahmen

Financial Services Roundup: Market Talk

4. Feb. 2026, 21:50 UTC

Market Talk
Ergebnisse

Auto & Transport Roundup: Market Talk

4. Feb. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

4. Feb. 2026, 21:45 UTC

Ergebnisse

Arm Holdings Reported Record Revenue. The Stock is Falling. -- Barrons.com

4. Feb. 2026, 21:44 UTC

Ergebnisse

Qualcomm Gives Weak Guidance. The CEO Blames Memory Crunch. -- Barrons.com

4. Feb. 2026, 21:43 UTC

Ergebnisse

Google to Double Spending as Earnings Beat Wall Street Expectations -- 2nd Update

4. Feb. 2026, 21:41 UTC

Ergebnisse

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4. Feb. 2026, 21:36 UTC

Market Talk

Latest Canada Green Bond Raises C$2 Billion -- Market Talk

4. Feb. 2026, 21:30 UTC

Ergebnisse

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4. Feb. 2026, 21:30 UTC

Ergebnisse

Alphabet Reports Solid Earnings. CapEx Heads Even Higher. -- Barrons.com

4. Feb. 2026, 21:30 UTC

Ergebnisse

Beach Energy Interim Dividend 1 Australian Cent/Sjare

4. Feb. 2026, 21:30 UTC

Ergebnisse

Steris Sees FY Adj EPS $10.15-Adj EPS $10.30 >STE

Peer-Vergleich

Kursveränderung

Pluristem Therapeutics Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

0

Buy

0

Halten

0

Sell

Finanzen

$

help-icon Live chat